PDE vs ADE vs HBEL vs MACO
What each concept means and how it drives cleaning limits.
Practical consulting, regulatory support, validation, training and licensing for pharmaceutical companies operating across the EU, UK, MENA and international markets.
One expert network supporting quality, regulatory, validation, technical operations and commercial expansion — from a single audit to a full local presence.
EU GMP, PQS/QMS, SOPs, deviations, CAPA, change control, OOS/OOT, QRM, supplier qualification and data integrity.
Request support →EU strategy, MAA pathways, CTD/eCTD review and preparation, CMC, variations, renewals and authority responses.
Review my dossier →VMP, URS, DQ/IQ/OQ/PQ, process and packaging validation, hold-time studies and lifecycle validation.
Plan validation →PDE/ADE/HBEL strategy, MACO, worst-case selection, sampling, recovery and legacy remediation.
Assess my program →GMP/GDP audits, mock inspections, supplier and CMO audits, pre-inspection readiness and remediation.
Prepare for inspection →CSV/CSA, GAMP 5, Annex 11, 21 CFR Part 11, LIMS/MES/eQMS validation, audit trails and ALCOA+.
Assess digital compliance →Formulation strategy, generic development, technology transfer, scale-up, stability and CMO/CDMO selection.
Discuss development →In-licensing, out-licensing, product sourcing, partner search, due diligence and EU–MENA market entry.
Explore an opportunity →QC systems, analytical validation and transfer, stability, instrument qualification and OOS/OOT.
Explore service →GMP facility design review, cleanrooms, HVAC, utilities, flows, commissioning and qualification.
Explore service →PV systems, PSMF/QPPV support, signal management, aggregate reports, audits and inspection readiness.
Explore service →Experienced QA, validation, regulatory and GMP resources for temporary leadership and execution.
Explore service →For upcoming inspections, critical GMP observations, authority deficiencies, major deviations, data-integrity findings, supplier failures and dossier issues.
Most clients start at one stage and stay for the rest. The order is a real sequence — each stage sets up the next.
Audits, gap analysis and quality-system remediation against EU GMP, GDP and data-integrity expectations.
Process, cleaning, computerized-system and facility validation across the full lifecycle.
EU strategy, CTD/eCTD preparation, MAA pathways, variations and authority responses.
In- and out-licensing, partner search and market entry across EU, UK and MENA.
Live online, on-site and customized corporate programs designed around practical GxP implementation, inspection expectations and risk-based decision-making — delivered by the same senior experts who run our projects.
Every course can be tailored to your products, processes and current findings — and mapped to specific roles across QA, Production, QC, Engineering, RA and Warehouse.
Core good-manufacturing-practice knowledge and a working quality system that survives inspection.
From master planning to lifecycle validation of equipment, processes and analytical methods.
Toxicology-based cleaning limits, worst-case rationale and remediation of legacy programs.
Building and maintaining dossiers that pass technical validation and authority review.
Computerized-system validation and data governance to current ALCOA+ expectations.
Preparing sites, teams and suppliers to face inspectors calmly and pass.
Distribution, responsible-person duties and pharmacovigilance across the supply chain.
Tailored curricula for whole sites and teams, built around your products and findings.
Durations are indicative · all courses available as tailored in-house sessions · certificates of attendance issued
European Pharma Experts is structured as an independent expert network, giving clients targeted support across quality, regulatory, validation, technical operations and business development.
Authoritative, practical content — built to inform your teams and attract the right enquiries.
What each concept means and how it drives cleaning limits.
Common quality gaps that delay regulatory submissions.
A practical readiness framework for manufacturing sites.
European Pharma Experts supports pharmaceutical companies with complex compliance, regulatory, validation and commercialization challenges. Our approach is risk-based, evidence-driven and focused on deliverables that work in real operations.
We bridge European regulatory expectations with the practical needs of manufacturers, developers, licensors, distributors and investors operating across international markets.
Share your challenge, market and timeline. EPE will route your enquiry to the appropriate expert.